Rapid urine drug of abuse rapid test of Singclean based on the qualitative immunoassay is for detection of recent drug involvement.
According to the report more than 35 million people worldwide are currently addicted to drugs. Rapid urine drug of abuse rapid test of Singclean based on the qualitative immunoassay is for detection of recent drug involvement, it can help a lot in drug control work.
Why choose Singclean?
Accurate results: according to international drug abuse monitoring standards;
Good specificity: select monoclonal antibody with high specificity to minimize possible crossover;
Easy to operate: do not need any equipment and additional testing; Samples are easy to collect and can be tested on site;
Fast detection: can be used to interpret the results in 5 minutes, saving time;
Joint testing: Multiple drugs can be screened at once, It can test various kinds of drugs like AMP / MET / MOR / THC / COC / PCP / BAR / BEN / MTD / TCA / MDMA / BUP in the urines sample at once.
Public security departments and anti-drug agencies to screen suspicious groups;
Conscription and admission physical examination;
Drug rehabilitation machine purchase treatment monitoring;
General survey, screening and physical examination of medical, health and epidemic prevention departments
Panel, Cassette, Cup
You can choose your ideal format as you like!
Q: Are you a manufacturer?
A: Yes, We manufacture products in our factory located in Hangzhou.
Q: What’s your main markets?
A: Europe, Asia, Central and South America, MENA, etc.
Q: What is your delivery term?
A: We accept FOB, CIF, etc. You can choose the one which is the most convenient or cost effective for you.
Q: What is the payment term?
A: We receive T/T, Western Union, Paypal, etc.
Q: Will you supply samples for test the quality?
A: We can send you paid or free samples for test , but the clients pay the express charge .
For more information and details, or you want to know about our other products, please feel free to contact firstname.lastname@example.org.
There are no reviews yet.